Hormone therapy is prescribed for troublesome symptoms during menopause.  While very effective in treating symptoms such as hot flashes, night sweats and mood changes, its use has declined due to safety concerns.  These safety concerns became very well publicized after the 2002 report from the Women’s Health Initiative study. Click here for more information.

Currently, the use of hormone therapy is still considered the gold standard for treating moderate to severe menopause symptoms.  Due to safety concerns, use is generally limited to the lowest effective dose for the shortest time frame.  However, women still have concerns about the potential risks associated with hormone therapy use.  Fortunately, there is new research showing a potential benefit to alternative ways that hormone therapy is administered. 

Hormone therapy is commonly administered in an oral tablet form.  However, hormones can also be delivered effectively via the skin in a transdermal patch form.  Due to the manner in which the hormone is metabolized once absorbed, practitioners have wondered if the patch is a safer way to deliver hormones.  Click here for more information. 

Good News for Women

Fortunately, two recent studies have found the transdermal patch to be a potentially safer way to administer menopause hormones.  Most recently, Dr. Suissa and colleagues from McGill University in Montreal reported that the use of a low dose estrogen patch does not seem to increase the risk of stroke(1).  In March, the same group reported that the patch was not associated with an increased risk of blood clots in postmenopausal women.  Read more…

Breaking News… on New Mammogram Recommendations

The medical staff at MenopauseRx, Inc. is more than a little surprised by the new recommendations of the U.S. Preventive Services Task Force (USPSTF). For the first time in 20 years, a government panel is telling women in there 40s to stop getting routine mammograms. The MenopauseRx staff is not alone in questioning these new guidelines.Many medical centers, breast cancer survivors, and thousands of health care providers, including doctors, are upset with these new recommendations.

“The new recommendations reduce women’s lives to numbers. The task force panel expressed concern that 1900 women age 40-49 will need to be screened with mammograms to save one life. That one life could be yours!”

See more at http://www.ez-llc.com/studio/eznewsletter/archive/9_248.htm

This month is National Osteoporosis Awareness and Prevention Month.  MenopauseRx would like to remind women that osteoporosis is especially prominent after the menopause transition.  Bone loss occurs during the perimenopause and after the menopause transition.  Unfortunately, the can lead to an increased risk of a serious fracture.  In fact, one out of every two women over the age of 50 will suffer from osteoporosis.  The goal of enhanced awareness is to reduce the widespread prevalence of osteoporosis and associated fractures and to find a cure for the disease through programs of awareness, education, advocacy and research.

Learn more at: http://www.menopauserx.com/health_center/health_Osteoporosis.htm

New eNewsletter Archive

MenopauseRx has created an easy to use archive of our latest newsletters for quick and easy review.

Here you’ll find past issues of our member’s only newsletters that contain news and study information related to your menopausal transition.

– To access the archive, click here.

Breaking News… on New Mammogram Recommendations

The medical staff at MenopauseRx, Inc. is more than a little surprised by the new recommendations of the U.S. Preventive Services Task Force (USPSTF). For the first time in 20 years, a government panel is telling women in there 40s to stop getting routine mammograms. The MenopauseRx staff is not alone in questioning these new guidelines. Many medical centers, breast cancer survivors, and thousands of health care providers, including doctors, are upset with these new recommendations.

Why did the USPSTF recommendations change?

Read more…